BSPK Stock Overview
Bespoke Extracts, Inc. provides hemp-derived cannabidiol (CBD) products.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Bespoke Extracts, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.11 |
| 52 Week High | US$1.00 |
| 52 Week Low | US$0.019 |
| Beta | 0.94 |
| 1 Month Change | -12.08% |
| 3 Month Change | 14.90% |
| 1 Year Change | 4.67% |
| 3 Year Change | -91.40% |
| 5 Year Change | -95.79% |
| Change since IPO | -100.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| BSPK | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | 0% | 0.08% | 1.2% |
| 1Y | 4.7% | 13.2% | 24.9% |
Return vs Industry: BSPK underperformed the US Pharmaceuticals industry which returned 13.2% over the past year.
Return vs Market: BSPK underperformed the US Market which returned 24.9% over the past year.
Price Volatility
| BSPK volatility | |
|---|---|
| BSPK Average Weekly Movement | 43.4% |
| Pharmaceuticals Industry Average Movement | 9.8% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: BSPK's share price has been volatile over the past 3 months.
Volatility Over Time: BSPK's weekly volatility has decreased from 65% to 43% over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Michael Feinsod | bespokeextracts.com |
Bespoke Extracts, Inc. provides hemp-derived cannabidiol (CBD) products. The company offers CBD formulations, including manuka honey and in the form of lotions and balms. It offers its products through its direct to consumers e-commerce store bespokeextracts.com.
Bespoke Extracts, Inc. Fundamentals Summary
| BSPK fundamental statistics | |
|---|---|
| Market cap | US$1.12m |
| Earnings (TTM) | -US$1.48m |
| Revenue (TTM) | US$785.45k |
1.4x
P/S Ratio-0.8x
P/E RatioIs BSPK overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BSPK income statement (TTM) | |
|---|---|
| Revenue | US$785.45k |
| Cost of Revenue | US$442.29k |
| Gross Profit | US$343.16k |
| Other Expenses | US$1.83m |
| Earnings | -US$1.48m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.15 |
| Gross Margin | 43.69% |
| Net Profit Margin | -188.79% |
| Debt/Equity Ratio | -52.4% |
How did BSPK perform over the long term?
See historical performance and comparison